Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zucman

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Journal of the International AIDS Society|February 21, 2020
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experimentChristel Protiere, Michael Arnold, Marion Fiorentino, et al.
Plos One|April 8, 2022
To what extent do people living with HIV, people on pre-exposure prophylaxis, doctors and pharmacists endorse 90-day dispensing of antiretroviral therapy in France?Christine Jacomet, Émilie Goncalves, Céline Lambert, et al.
AIDS (London, England)|February 2, 2016
Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokersAlain Makinson, Sabrina Eymard-Duvernay, François Raffi, et al.
HIV Medicine|July 2, 2021
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participantsMathieu Chalouni, Linda Wittkop, Firouzé Bani-Sadr, et al.
Journal of Hepatology|August 18, 2020
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related deathMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.
The Lancet. HIV|January 14, 2018
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trialPatrick Mercié, Julie Arsandaux, Christine Katlama, et al.
Plos One|August 10, 2016
Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 ParticlesChiraz Hamimi, Annie David, Pierre Versmisse, et al.
HIV Medicine|August 17, 2021
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysisMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2014
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimensJade Ghosn, Marianne Leruez-Ville, Jérôme Blanche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2015
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH StudyLionel Piroth, Hubert Paniez, Anne Marie Taburet, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Journal of the International AIDS Society|February 21, 2020
Differences in HIV cure clinical trial preferences of French people living with HIV and physicians in the ANRS-APSEC study: a discrete choice experimentChristel Protiere, Michael Arnold, Marion Fiorentino, et al.
Plos One|April 8, 2022
To what extent do people living with HIV, people on pre-exposure prophylaxis, doctors and pharmacists endorse 90-day dispensing of antiretroviral therapy in France?Christine Jacomet, Émilie Goncalves, Céline Lambert, et al.
AIDS (London, England)|February 2, 2016
Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokersAlain Makinson, Sabrina Eymard-Duvernay, François Raffi, et al.
HIV Medicine|July 2, 2021
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participantsMathieu Chalouni, Linda Wittkop, Firouzé Bani-Sadr, et al.
Journal of Hepatology|August 18, 2020
Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related deathMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.
The Lancet. HIV|January 14, 2018
Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trialPatrick Mercié, Julie Arsandaux, Christine Katlama, et al.
Plos One|August 10, 2016
Dendritic Cells from HIV Controllers Have Low Susceptibility to HIV-1 Infection In Vitro but High Capacity to Capture HIV-1 ParticlesChiraz Hamimi, Annie David, Pierre Versmisse, et al.
HIV Medicine|August 17, 2021
Direct, indirect and total effect of HIV coinfection on the risk of non-liver-related cancer in hepatitis C virus-infected patients treated by direct-acting antivirals: a mediation analysisMathieu Chalouni, Stanislas Pol, Philippe Sogni, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2014
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimensJade Ghosn, Marianne Leruez-Ville, Jérôme Blanche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 16, 2015
High Cure Rate With 24 Weeks of Daclatasvir-Based Quadruple Therapy in Treatment-Experienced, Null-Responder Patients With HIV/Hepatitis C Virus Genotype 1/4 Coinfection: The ANRS HC30 QUADRIH StudyLionel Piroth, Hubert Paniez, Anne Marie Taburet, et al.
Pageof 8